HMN 2025: How a drug used to deal with Parkinson’s illness may have an effect on the mind

Simon Fraser University researchers are utilizing a brand new method to mind imaging that would enhance how medicine are prescribed to deal with Parkinson’s illness.

The new study, published within the journal Movement Disorders, appears to be like at why levodopa—the primary drug utilized in dopamine alternative remedy—is typically much less efficient in sufferers.

The drug is often prescribed to assist cut back the motion signs related to the neurodegenerative dysfunction. While it’s efficient in enhancing signs for the overwhelming majority of sufferers, not everybody experiences the identical degree of profit.

In order to find out why, an SFU collaboration with researchers in Sweden has used magnetoencephalography (MEG) know-how to find out how the drug impacts alerts within the mind.

“Parkinson’s is the second most prevalent neurodegenerative illness worldwide and it’s the most quickly growing, when it comes to incidence,” says Alex Wiesman, assistant professor of biomedical physiology and kinesiology at SFU. “Treating this illness, each when it comes to serving to folks with their signs, but in addition looking for methods to reverse the results, is turning into an increasing number of necessary. If clinicians can see how levodopa prompts sure elements of the mind in a affected person, it will probably assist to tell a extra personalised method to remedy.”

The study was a collaboration with researchers at Karolinska Institutet in Sweden, who used MEG to gather information from 17 sufferers with Parkinson’s illness—a comparatively small pattern measurement. Researchers mapped members’ mind alerts earlier than and after taking the drug, with a purpose to see how and where the drug impacted mind exercise.

MEG is a sophisticated non-invasive know-how that measures the magnetic fields produced by the mind’s electrical alerts. It may help clinicians and researchers to review mind problems and ailments, together with mind accidents, tumors, epilepsy, autism, psychological sickness and extra.

Using this uncommon mind imaging know-how, Wiesman and staff developed a brand new evaluation that lets them “search” the mind for off-target drug results.

“With this new manner of analyzing mind imaging information, we will monitor in actual time whether or not or not the drug is affecting the appropriate mind areas and serving to sufferers to handle their signs,” says Wiesman. “What we discovered was that there are generally ‘off-target’ results of the drug. In different phrases, we may see the drug activating mind areas we do not need to be activating and that is getting in the best way of the useful results. We discovered that these individuals who confirmed ‘off-target’ results are nonetheless being helped by the drug, however to not the identical extent as others.”

Parkinson’s illness is a neurodegenerative dysfunction, which means elements of the mind grow to be progressively broken over time. It predominantly impacts the dopamine-producing neurons in a selected space of the mind referred to as the substantia nigra. People with Parkinson’s illness might {experience} a variety of movement-related signs, equivalent to tremors, sluggish motion, stiffness and stability issues.

Wiesman hopes that a greater understanding of how levodopa impacts a person’s mind alerts may enhance how medicine are prescribed to deal with Parkinson’s.

“This is likely to be actually useful for monitoring individualized responses to a lot of these medicine and serving to with prescribing and therapeutics,” he says.

“So perhaps we attempt totally different drugs, perhaps we alter dosages otherwise. And this helps clinicians get at that query of how we prescribe personalised medication in a manner that basically helps the affected person. The extra we will personalize that method, make it extra expedient, make it a bit extra particular to that particular person, the higher.”

This new kind of mind imaging evaluation shouldn’t be just for finding out Parkinson’s illness; any drugs that have an effect on mind signaling could be studied utilizing the tactic developed by Wiesman and colleagues.

SFU’s ImageTech Lab, on the Surrey Memorial Hospital, is residence to the one MEG in western Canada.

“We have this actually incredible know-how proper right here at SFU, and mixed with the brand new evaluation approaches that we’re creating, it offers us a extremely unprecedented look into what’s taking place within the mind,” says Wiesman. “We can use this know-how shifting ahead to review Parkinson’s illness in ways in which nobody has ever accomplished earlier than worldwide.

“Our subsequent step is to take our new method and apply it to a bigger affected person group. We additionally have to translate this analysis to extra accessible mind imaging strategies, like electroencephalogram (EEG). Ultimately, we need to be certain that this know-how is helpful for a various inhabitants and extra extensively accessible to sufferers with Parkinson’s illness.”